Attached files

file filename
EX-10.30 - EX-10.30 - PURE BIOSCIENCE, INC.pure-20150731ex1030f33f8.htm
EX-31.1 - EX-31.1 - PURE BIOSCIENCE, INC.pure-20150731ex311d116de.htm
EX-32.2 - EX-32.2 - PURE BIOSCIENCE, INC.pure-20150731ex32294ceb0.htm
EX-10.32 - EX-10.32 - PURE BIOSCIENCE, INC.pure-20150731ex103281bcb.htm
EX-10.31 - EX-10.31 - PURE BIOSCIENCE, INC.pure-20150731ex10315814e.htm
EX-32.1 - EX-32.1 - PURE BIOSCIENCE, INC.pure-20150731ex3212f47bc.htm
EX-31.2 - EX-31.2 - PURE BIOSCIENCE, INC.pure-20150731ex312bfbc9d.htm
EX-4.12 - EX-4.12 - PURE BIOSCIENCE, INC.pure-20150731ex412cbfd92.htm
EX-4.11 - EX-4.11 - PURE BIOSCIENCE, INC.pure-20150731ex411ef48a6.htm
10-K - 10-K - PURE BIOSCIENCE, INC.pure-20150731x10k.htm

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-199240 on Form S-1, in Post-Effective Amendment No. 1 to Registration Statement Nos. 333-88648, 333-114754, and 333-143378 on Form S-8 and in Registration Statement Nos. 333-205108 and 333-192397 on Form S-8, of our report dated October 28, 2015, relating to the consolidated financial statements of Pure Bioscience, Inc. appearing in this Annual Report on Form 10-K for the year ended July 31, 2015.

/s/ Mayer Hoffman McCann P.C.

San Diego, California

October 28, 2015